Intelligent systems increasingly speed up and disrupt status-quo processes. To say that change is a constant is an understatement with the coronavirus turning the whole world upside down. Paired with accelerating cloud technologies where there seems to be no "finish line," we find ourselves in an environment that is more and more of a challenge for the IT skills of internal teams to keep up. In one of my previous articles "3 Steps To Address The Cloud Talent Drought," we found that relieving the growing skills gap is becoming a great motivator for increased automation, driven by artificial intelligence (AI) and Machine Learning (ML). After this pandemic is over, there will be business winners and losers.
With the number of Coronavirus cases increasing every day, it is evident that the entire world is struggling to triumph over this deadly disease. While the top health organizations are aiding funds to facilitate research, many believe that the artificial intelligence might help in decelerating the crisis. Let's have a look at how artificial intelligence can help in overcoming this pandemic situation: Artificial Intelligence, aka AI, may see coming pandemics, which will give us sufficient time to prepare. According to Forbes, a Canada based development company had warned of this threat a few days before the authorities issued public warnings. This clearly depicts that the earlier we can track the virus, the better we can fight it.
From developing drug treatments to predicting the next hotspot, artificial intelligence may help researchers, healthcare workers, and everyday people offset the impact of the coronavirus. As the worldwide fight against coronavirus COVID-19 continues, companies and governments around the world are pulling out all the stops in an effort to stave off the pandemic's worst impacts. One tool in that toolbox that might prove particularly useful is artificial intelligence (AI). Even though AI has been around since the 1960s, it's only been in the past few years that its adoption outside of science labs and research institutions has really taken off. Perhaps the most common application of AI people have come into contact with today are virtual assistants like Apple's Siri and Amazon's Alexa, which rely on natural language processing (NLP) algorithms to understand human speech.
From working to accelerate insights into Coronavirus, to striving to manage supply chains the midst of social distancing, governments and enterprises are figuring out how to make optimal decisions during times of uncertainty and emotion. Sadly, despite many advances in predictive analytics, AI technologies – unless used within an augmented intelligence framework that combines both machine and human intelligence – often fall short of expectations. Join Genpact's Analytics Business Leader Amaresh Tripathy and guest Dr. Kjell Carlsson from Forrester to discuss how smart organizations are leveraging augmented intelligence to help ensure accuracy and relevancy of decisions and better outcomes. Genpact and Forrester will share examples from Fortune 500 leaders – across banking, consumer goods, retail, life sciences and health care – who are harnessing the power of augmented intelligence during this period of crisis.
Hong Kong/Beijing/Seoul/Tokyo – Fitness-tracking gadgets are selling out, home exercise classes have never been more popular and robotics crews are pivoting to making sanitation robots. The Covid-19 pandemic has triggered a seismic wave of health awareness and anxiety, which is energizing a new category of virus-fighting tech. The fear of infection has accelerated the adoption of apps and wearables as a means to feel better protected. "Having accurate and immediate feedback about our body temperature, blood pressure and other health signals helps to restore people's sense of control," said Andy Yap, a social psychologist at the INSEAD business school. Consumers, insurers and health-care providers are all seeing the benefit of the gadgets, in a shift expected to persist long after the outbreak subsides.
The COVID-19 outbreak has spurred considerable news coverage about the ways artificial intelligence (AI) can combat the pandemic's spread. Unfortunately, much of it has failed to be appropriately skeptical about the claims of AI's value. Like many tools, AI has a role to play, but its effect on the outbreak is probably small. While this may change in the future, technologies like data reporting, telemedicine, and conventional diagnostic tools are currently far more impactful than AI. Still, various news articles have dramatized the role AI is playing in the pandemic by overstating what tasks it can perform, inflating its effectiveness and scale, neglecting the level of human involvement, and being careless in consideration of related risks. In fact, the COVID-19 AI-hype has been diverse enough to cover the greatest hits of exaggerated claims around AI.
VARESE, Italy (Reuters) - He doesn't wear a mask but he is helping save lives from coronavirus just the same. Tommy is one of six new robots helping flesh-and-blood doctors and nurses care for coronavirus patients at the Circolo Hospital in Varese, a city in the northern Lombardy region that is the epicenter of the outbreak in Italy. "It's like having another nurse without problems related to infection," said Doctor Francesco Dentali, director of intensive care at the hospital. The child-size robots with large blinking eyes are wheeled into rooms and left by a patient's bedside so doctors can look after others who are in more serious conditions. They monitor parameters from equipment in the room, relaying them to hospital staff.
In the heart of Silicon Valley, Stanford clinicians and researchers are exploring whether artificial intelligence could help manage a potential surge of Covid-19 patients -- and identify patients who will need intensive care before their condition rapidly deteriorates. The challenge is not to build the algorithm -- the Stanford team simply picked an off-the-shelf tool already on the market -- but rather to determine how to carefully integrate it into already-frenzied clinical operations. "The hardest part, the most important part of this work is not the model development. But it's the workflow design, the change management, figuring out how do you develop that system the model enables," said Ron Li, a Stanford physician and clinical informaticist leading the effort. Li will present the work on Wednesday at a virtual conference hosted by Stanford's Institute for Human-Centered Artificial Intelligence.
Note– To all those who have lost the hope at the end of Corona Virus spread, here's some good news. Fujifilm's Pharmaceutical branch has started its phase 3 test trials of its Avigan (Favipiravir) drug from Tuesday to those infected with COVID 19 in Japan. It is reported that the drug stands as a one-shot antiviral drug solution against 18 types of flu and might prove effective getting rid of Corona Pandemic from the infected nations. So, the clinical trials made on the infected people in Japan have yielded excellent results and have already clinically proven by experts that it can eradicate the Ebola Virus to the core. Already Fujifilm has ramped its production in March 2020 after it started its trials in November 2019 after seeing the spread of the Wuhan Virus in China.